Novel Replication-Incompetent Vector Derived from Adenovirus Type 11 (Ad11) for Vaccination and Gene Therapy: Low Seroprevalence and Non-Cross-Reactivity with Ad5

A novel plasmid-based adenovirus vector system that enables manufacturing of replication-incompetent (ΔE1) adenovirus type 11 (Ad11)-based vectors is described. Ad11 vectors are produced on PER.C6/55K cells yielding high-titer vector batches after purification. Ad11 seroprevalence proves to be signi...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:J Virol
Main Authors: Holterman, Lennart, Vogels, Ronald, van der Vlugt, Remko, Sieuwerts, Martijn, Grimbergen, Jos, Kaspers, Jorn, Geelen, Eric, van der Helm, Esmeralda, Lemckert, Angelique, Gillissen, Gert, Verhaagh, Sandra, Custers, Jerome, Zuijdgeest, David, Berkhout, Ben, Bakker, Margreet, Quax, Paul, Goudsmit, Jaap, Havenga, Menzo
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society for Microbiology (ASM) 2004
נושאים:
Gene Therapy
גישה מקוונת:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC525025/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15542673/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.78.23.13207-13215.2004
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים